Allogenic T-cell-based immunotherapy for PML in development Presented ByDr George Ambalathingal, QIMR Berghofer Medical Research Institute, Australia TrialPhase 2, CE-VST01-JC ConferenceAAN 2023 26 June, 2023 19:32